Coherent Stock Rises 8% in a Month: Is the Buying Opportunity Intact?

Coherent shares rose 8% in the past month and 190% over the past year as AI-driven optical-networking demand strengthens its outlook. Fiscal 2027 revenue is estimated at $10.68 billion, up 50%, and EPS at $9.38, up 67.2%; fiscal 2027 demand is strongly committed, with customer purchase orders extending into calendar 2028. The 1.6T transceiver ramp and nearly 80% year-over-year increase in InP laser production support growth, though COHR’s 32.06x forward P/E is above the industry’s 20.77x.

Analysis

The key question is conversion, not demand rhetoric: committed orders only support the premium if Coherent ships on time, sustains yields, and turns higher volumes into better gross margins and cash generation. Capacity expansion creates a second-order risk: if new InP capacity or 1.6T ramps lag, revenue slips while fixed costs rise; if capacity catches up faster than customer deployments, utilization and pricing could disappoint. Predetermined pricing in some longer-term agreements may also limit upside if input costs or product mix move adversely.

Over the next 1–3 months, shipment cadence, yield commentary, customer qualification and guidance matter more than broad AI capex narratives. Over 6–18 months, architecture is the structural risk: co-packaged optics and other designs may expand the addressable market, but could also shift value among component and subsystem vendors. A broad portfolio reduces dependence on one standard, not the risk of losing economics to customer-designed or competing solutions. LITE and AAOI are useful read-throughs on supplier demand, but not clean substitutes without comparing product mix, execution and valuation.

Contrarian view: the article treats order visibility as earnings certainty. It is not; timing, cancellation terms, concentration and margin content are unverified here. After the large rerating, any estimate reset can compress a premium multiple even if end-market demand remains healthy. Bull case remains intact if reported shipments and margins validate the ramp; otherwise, the stock can fall on execution rather than an AI-demand collapse.

Key Decisions for Investors

• Do not chase the recent rally solely on order-book claims. For existing exposure, retain a core position but size additions around reported execution rather than headline demand.
• Consider staged entries on weakness only if upcoming results confirm 1.6T shipment growth, improving manufacturing yields and gross-margin progress. Avoid a directional options trade without current implied-volatility and skew data.
• Track order-to-revenue conversion, cancellation and minimum-purchase terms, customer concentration, capacity utilization, and cash conversion. Treat missed shipment milestones or weaker margin guidance as a thesis warning.
• Reassess the premium if guidance or estimates are cut, or if revenue growth fails to translate into margin and cash-flow improvement; continued demand alone would not falsify the valuation risk.